Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TVM
Biotech
Lilly regains an oncology asset in up-to-$575M AurKa deal
Eli Lilly is handing over $110 million up front for AurKa Pharma, regaining an asset it sold off in 2016.
Amirah Al Idrus
May 14, 2018 10:50am
Rapid Micro bags $60M to grow microbial detection business
May 2, 2018 12:01am
Centogene raises $28M to fuel expansion in the U.S. and China
Jun 14, 2017 2:23am
Neurimmune, TVM set up ALS biotech, secure Lilly support
Dec 7, 2016 7:21am
